Apr 23 |
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
|
Apr 22 |
Moderna stock closes in green after eight sessions of losses
|
Apr 22 |
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
|
Apr 19 |
Moderna (MRNA) Stock Moves -0.58%: What You Should Know
|
Apr 19 |
Moderna stock traded in the red for the eighth straight day
|
Apr 19 |
FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
|
Apr 17 |
Moderna (MRNA) Stock Moves -0.34%: What You Should Know
|
Apr 17 |
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
|
Apr 17 |
Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
|
Apr 16 |
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
|